NASDAQ · PFSAHealthcareSurgical Instruments

Profusa financials

$2.27+34.32%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
Revenue$0.00
Gross profit$0.00
Gross margin—
Operating income-$27.7M
Net income-$35.8M
Net margin—
Diluted EPS$-107.01
EBITDA-$27.7M
Operating cash flow-$16.2M
Free cash flow-$16.3M
Diluted shares0.3M

Balance sheet

Period endDec 31
Cash & equivalents$1.8M
Short-term investments$0.00
Total debt$10.3M
Total assets$3.8M
Total liabilities$30.4M
Shareholders' equity-$26.7M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology